X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
female (14) 14
male (14) 14
adult (12) 12
chemistry (11) 11
human necessities (11) 11
hygiene (11) 11
medical or veterinary science (11) 11
metallurgy (11) 11
middle aged (11) 11
organic chemistry (11) 11
preparations for medical, dental, or toilet purposes (11) 11
specific therapeutic activity of chemical compounds ormedicinal preparations (11) 11
index medicus (10) 10
aged (8) 8
clinical neurology (8) 8
acyclic or carbocyclic compounds (5) 5
apparatus therefor (5) 5
general methods of organic chemistry (5) 5
investigating or analysing materials by determining theirchemical or physical properties (5) 5
measuring (5) 5
peptides (5) 5
physics (5) 5
testing (5) 5
treatment outcome (5) 5
after-treatment of the shaped products, e.g. repairing (4) 4
amyotrophic lateral sclerosis (4) 4
amyotrophic lateral sclerosis - diagnosis (4) 4
genetic counseling (4) 4
indexing scheme associated with subclass b29c, relating to particulararticles (4) 4
indexing scheme associated with subclasses b29b, b29c or b29d, relating to moulding materials (4) 4
neurosciences (4) 4
performing operations (4) 4
removable external protective coverings specially adapted forvehicles (4) 4
shaping of material in a plastic state, not otherwise providedfor (4) 4
shaping or joining of plastics (4) 4
transporting (4) 4
vehicles in general (4) 4
vehicles, vehicle fittings, or vehicle parts, not otherwiseprovided for (4) 4
windows, windscreens, non-fixed roofs, doors, or similardevices for vehicles (4) 4
working of plastics (4) 4
working of substances in a plastic state, in general (4) 4
aged, 80 and over (3) 3
amyotrophic lateral sclerosis - drug therapy (3) 3
antipyrine - analogs & derivatives (3) 3
biomarkers - blood (3) 3
double-blind method (3) 3
magnetic resonance imaging (3) 3
mci-186 (3) 3
neurology (3) 3
parkinson's disease (3) 3
administration, oral (2) 2
animals (2) 2
antipyrine - adverse effects (2) 2
antipyrine - therapeutic use (2) 2
autoantibodies - blood (2) 2
beer (2) 2
biochemistry (2) 2
biochemistry & molecular biology (2) 2
brain - pathology (2) 2
camp (2) 2
collagen (2) 2
communication (2) 2
compositions or test papers therefor (2) 2
condition-responsive control in microbiological orenzymological processes (2) 2
disease (2) 2
drug therapy, combination (2) 2
edaravone (2) 2
enzymology (2) 2
fibrosis (2) 2
free radical scavengers - adverse effects (2) 2
free radical scavengers - therapeutic use (2) 2
genetic testing (2) 2
informed consent (2) 2
japan (2) 2
liver transplantation (2) 2
measuring or testing processes involving enzymes, nucleicacids or microorganisms (2) 2
methylprednisolone - administration & dosage (2) 2
microbiology (2) 2
muscle (2) 2
muscle, skeletal - metabolism (2) 2
mutation or genetic engineering (2) 2
parkinson disease - complications (2) 2
processes of preparing such compositions (2) 2
pulse therapy, drug (2) 2
revised als functional rating scale (2) 2
rodents (2) 2
sildenafil (2) 2
spirits (2) 2
stroke (2) 2
surgery (2) 2
therapy (2) 2
tomography, x-ray computed (2) 2
vinegar (2) 2
wine (2) 2
1506 (1) 1
4q25-7 (1) 1
4q35- ter (1) 1
abridged index medicus (1) 1
absence (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FASEB Journal, ISSN 0892-6638, 2017, Volume 31, Issue 12, pp. 5307 - 5320
Duchenne muscular dystrophy (DMD) is the most common inherited muscular dystrophy. Patients experience DMD in their 20s from cardiac or respiratory failure... 
Muscle fibrosis | DMD | Sildenafil | Piclamilast | FIBROSIS | RESVERATROL | CELLS | TGF-BETA | muscle fibrosis | BIOCHEMISTRY & MOLECULAR BIOLOGY | MUSCLE | piclamilast | sildenafil | CELL BIOLOGY | MOUSE MODEL | BIOLOGY | NITRIC-OXIDE | OXIDE SYNTHASE TRANSGENE | EXPRESSION | Fibrosis - drug therapy | Muscular Dystrophy, Animal - drug therapy | Sildenafil Citrate - therapeutic use | Male | Muscle, Skeletal - metabolism | Fibrosis - metabolism | Benzamides - therapeutic use | Muscle, Skeletal - drug effects | Mice, Inbred mdx | Muscular Dystrophy, Animal - metabolism | Anti-Inflammatory Agents - therapeutic use | Phosphodiesterase 5 Inhibitors - therapeutic use | PPAR gamma - genetics | Pyridines - therapeutic use | Fibrosis - enzymology | Muscular Dystrophy, Duchenne - drug therapy | Mice, Inbred C57BL | RNA, Messenger - genetics | Muscular Dystrophy, Duchenne - enzymology | Phosphodiesterase 4 Inhibitors - therapeutic use | Animals | Muscular Dystrophy, Animal - enzymology | Muscle Contraction - drug effects | Mice | Muscular Dystrophy, Duchenne - metabolism | Therapy | Animal models | Cardiac muscle | Therapeutic applications | Muscles | Phosphodiesterase IV | Pharmacology | Inflammation | mRNA | Chemical compounds | Muscular dystrophy | Inhibitors | Ischemia | Rodents | Collagen | Duchenne's muscular dystrophy | Fibrosis | Diaphragm (anatomy) | Dystrophy | Diaphragm | Heart diseases | Phosphodiesterase
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2017, Volume 16, Issue 7, pp. 505 - 512
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 08/2016, Volume 87, Issue 8, pp. 907 - 910
Introduction Anticollapsin response mediator protein 5 antibody (anti-CRMP5 antibody, also known as anti-CV2 antibody) is usually associated with small-cell... 
PARANEOPLASTIC SYNDROME | MOVEMENT DISORDERS | NEUROIMMUNOLOGY | NEUROONCOLOGY | Parkinson'S DISEASE | SURGERY | DISORDERS | AUTOANTIBODY | AUTOIMMUNITY | PSYCHIATRY | CLINICAL NEUROLOGY | Antigens | Nervous system | Immunoglobulins | Chemotherapy | Metabolism | Patients | PARKINSON'S DISEASE | 1506 | PostScript
Journal Article
Bioscience, Biotechnology, and Biochemistry, ISSN 0916-8451, 06/2019, Volume 83, Issue 6, pp. 1000 - 1010
Pulmonary hypertension (PH) is a life-threatening lung disease. PH with concomitant lung diseases, e.g., idiopathic pulmonary fibrosis, is associated with poor... 
cAMP | cGMP | rat model of monocrotaline-induced pulmonary hypertension | FIBROSIS | SILDENAFIL | SMAD3 | PHOSPHODIESTERASE-4 INHIBITOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | FOOD SCIENCE & TECHNOLOGY | THERAPY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CHEMISTRY, APPLIED | ROFLUMILAST
Journal Article
Parkinsonism and Related Disorders, ISSN 1353-8020, 01/2016, Volume 22
Journal Article
Parkinsonism and Related Disorders, ISSN 1353-8020, 2015, Volume 22, pp. e99 - e100
Journal Article
by Yamagami, Keitaro and Kurogi, Ryota and Kurogi, Ai and Nishimura, Hiroyuki and Nishimura, Shinjitsu and Nishimura, Yasuaki and Nishimura, Kunihiro and Nishimura, Ataru and Onozuka, Daisuke and Ren, Nice and Kada, Akiko and Arimura, Koichi and Ido, Keisuke and Mizoguchi, Masahiro and Sakamoto, Seisaburo and Sakamoto, Tetsuya and Kayama, Takamasa and Suzuki, Nozomi and Suzuki, Michiyasu and Suzuki, Sachio and Suzuki, Hidenori and Suzuki, Ichiro and Suzuki, Susumu and Arai, Yoshinori and Arai, Hajime and Arai, Motohiro and Hagihara, Akihito and Iihara, Koji and Takigami, Masayoshi and Kamiyama, Kenji and Houkin, Kiyohiro and Nishi, Shougo and Yoshimoto, Tetsuyuki and Yoshimoto, Junpei and Kaneko, Sadao and Oka, Hirofumi and Oka, Koji and Ooyama, Hiroshi and Kamada, Kyousuke and Makino, Kenichi and Tokumitsu, Naoki and Sako, Kazuhiro and Izumi, Naoto and Nitta, Hisashi and Nitta, Kazumi and Ootaki, Masahumi and Isobe, Masanori and Nishiya, Mikio and Yamazaki, Takaaki and Mabuchi, Syouji and Mabuchi, Eiichiro and Ogasawara, Kuniaki and Kubo, Naohiko and Shimizu, Yukihiko and Saito, Hitoshi and Saito, Keiichi and Yamanome, Tatumi and Yoshino, Kimihiro and Yoshino, Atsuo and Fujitsuka, Mitsuyuki and Takami, Masaaki and Ohtaka, Hirotoshi and Hirano, Teruyuki and Shiokawa, Yosiaki and Okada, Takaharu and Kohno, Michihiro and Haraoka, Jou and Kawamura, Noriyoshi and Kawamura, Tadao and Isoshima, Akira and Yasue, Masaharu and Takayoshi Kobayashi, Mitsuhiko Hokari and Kawai, Kensuke and Maehara, Taketoshi and Noguchi, Makoto and Hoshino, Haruhiko and Hiyama, Hirofumi and Yoshida, Kensaku and Yoshida, Kazunari and Utsugi, Osamu and Takeda, Yasuaki and Takeda, Yuu and Tamaki, Kouichi and Karasudani, Hirohide and Urabe, Takao and Kobayashi, Nozomu and Kobayashi, Shiro and Nakamura, Yusaku and Nakamura, Kazuhito and Nakamura, Michio and Nakamura, Yoshinari and Koguchi, Yorio and Ono, Junichi and Suda, Sumio and Hadeishi, Hiromu and Fukutake, Toshio and Wakui, Kenji and Tanno, Hirokazu and Ishige, Naoki and Ohasi, Takashi and ... and J-ASPECT Study Collaborators
World Neurosurgery, ISSN 1878-8750, 10/2019, Volume 130, pp. e26 - e46
The epidemiology of patients with traumatic brain injury (TBI) has changed dramatically over recent decades as a result of rapid advances in aging societies.... 
Aging | Hospital mortality | Prognosis | Traumatic brain injury | Subdural hematoma | SURGERY | CARE | CLINICAL NEUROLOGY | IMPACT | CLINICAL-VARIABLES | HOSPITAL VOLUME | GENDER | COMA
Journal Article
Physiological Reports, 06/2018, Volume 6, Issue 12, pp. e13753 - n/a
Fibrosis of the lung constitutes a major clinical challenge and novel therapies are required to alleviate the associated morbidity and mortality. Investigating... 
collagen | pulmonary | epithelium | fibroblast | cAMP
Journal Article
Medical Hypotheses, ISSN 0306-9877, 2012, Volume 80, Issue 2, pp. 209 - 212
Abstract Parkinson’s disease (PD) is a neurodegenerative disorder characterized by a variety of motor symptoms including freezing of gait (FOG), in which... 
Internal Medicine
Journal Article
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, ISSN 2167-8421, 10/2017, Volume 18, Issue sup1, pp. 55 - 63
Journal Article